Emami Ltd Q2 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/g2ytwzfx0ucczfldt8pghq9w.pdf

Key Takeaways


The GST Shock and Recovery

Mohan Goenka: "I'm just being a little conservative, Arnab, because winter, as I said, has started with a very fine note, but it's yet to get into the winter season, okay? But you are right, I'm confident of double digit, not that I'm not. If the winter goes on like this, then nothing can stop for double digit for sure."

Kesh King: The Big Repositioning Bet

Mohan Goenka: "I think this was a very important move because Kesh King faced significantly challenge from the D2C brands, particularly for hair fall categories, okay? And most of the D2C brands are science packed. So that is the need of the young consumers. That is where the trend is going."

Strategic Investments and Channel Shifts

Mohan Goenka: "Not really. These are absolutely at different price points and different categories altogether. It will not compete with the TMC. Definitely, yes, there is a structural shift that's why such bold steps are being taken. Face cream demand is not as high as it used to be."

International and Healthcare


Margins and Profitability


Guidance & Commitments

CommitmentSpecificsTimeline
GST destocking recovery4% GST-driven destocking to be fully recoveredQ3 FY26
Strategic investments growthGrowth rate to accelerate to strong double digits, higher than H1H2 FY26
Margin recoveryMargin expansion, high growth in EBITDA and net margins expectedQ3 FY26
Kesh King Gold relaunchBacked by a huge advertising campaignUnderway (launched last month)
Smart and Handsome rolloutRange to be rolled out to other e-commerce sites and modern tradeNo date (test marketing stage)
FY27 outlookShould definitely be much better than FY26, starting with a lower summer base and strengthened pillarsFY27

Key Metrics

MetricQ2 FY26
Consolidated revenue₹799 cr, declined 10% YoY
Domestic business revenueDeclined 15% YoY
Domestic volume decline~16% YoY
Gross margin71%, stable YoY
EBITDA₹179 cr, declined 29% YoY
PAT₹148 cr, declined 30% YoY
Interim dividend₹4 per share (400%), declared for FY26
International business growth8% YoY primary sale growth
Strategic investments portfolio growth16% YoY, 36% sequential
Honey growth36% YoY
Zandu Care growth17% YoY
Medico business growth~8% YoY
SAARC markets growthOver 22% YoY, including Bangladesh
Nepal growthAlmost 100% YoY
Quick commerce saliency~14% of e-com, ~11% of domestic consumer business
Portfolio with grammage increase post-GST20% of portfolio (sachets), balance reduced MRP
MRP reduction across domestic portfolio~₹250–260 cr
Core domestic portfolio benefiting from GST cut88% of portfolio
Total portfolio at 5% GST rate~93%